Bloodstream infections among patients treated with intravenous epoprostenol or intravenous treprostinil for pulmonary arterial hypertension - Seven sites, United States, 2003-2006

R. Barst, E. Berman-Rosenzweig, E. Horn, L. Saiman, L. Lee, K. Southwick, D. Kohlerschmidt, P. Smith, M. Gomberg-Maitland, S. Weber, D. Ivy, A. Doran, M. McGoon, C. Anderson Severson, M. Rubenfire, V. McLaughlin, J. Feldman, C. Tanner, K. Chin, M. KingmanV. Tapson, A. Srinivasan, J. Noble-Wang, M. Arduino, R. Shoulson, E. Petersen, A. Kallen, E. Lederman, A. Balaji, I. Trevino

Research output: Contribution to journalComment/debate

75 Scopus citations
Original languageEnglish (US)
Pages (from-to)170-172
Number of pages3
JournalMorbidity and Mortality Weekly Report
Volume56
Issue number8
StatePublished - Mar 2 2007

ASJC Scopus subject areas

  • Epidemiology
  • Health(social science)
  • Health, Toxicology and Mutagenesis
  • Health Information Management

Cite this

Barst, R., Berman-Rosenzweig, E., Horn, E., Saiman, L., Lee, L., Southwick, K., Kohlerschmidt, D., Smith, P., Gomberg-Maitland, M., Weber, S., Ivy, D., Doran, A., McGoon, M., Anderson Severson, C., Rubenfire, M., McLaughlin, V., Feldman, J., Tanner, C., Chin, K., ... Trevino, I. (2007). Bloodstream infections among patients treated with intravenous epoprostenol or intravenous treprostinil for pulmonary arterial hypertension - Seven sites, United States, 2003-2006. Morbidity and Mortality Weekly Report, 56(8), 170-172.